Drug-labels.com

Glyburide (Pro Doc): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
2.5 mg, 5 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Glyburide (Pro Doc)

ABOUT THIS MEDICATION

What the medication is used for:

GLYBURIDE (glyburide) is used as an adjunct to proper diet, exercise and weight reduction to lower blood glucose in adult patients with type 2 diabetes mellitus.

What it does:

GLYBURIDE lowers blood sugar by stimulating the pancreas to secrete insulin. The pancreas must produce insulin for this medication to work.

People with type 2 diabetes are not able to make enough insulin or respond normally to the insulin their bodies make. When this happens, sugar (glucose) builds up in the blood. This can lead to serious medical problems including kidney damage, amputations, and blindness. Diabetes is also closely linked to heart disease. The main goal of treating diabetes is to lower

your blood sugar to a normal level and by doing so can prevent long term complications.

In addition to taking GLYBURIDE, you should continue to exercise and follow the diet recommended for you by your doctor.

When it should not be used:

Do not take GLYBURIDE (glyburide):

  • If you have Type 1 diabetes.
  • If you have known hypersensitivity or allergy to this

    drug, any sulfonylurea or sulfonamides, or to any ingredient in the formulation or component of the container.

  • If you have diabetic ketoacidosis (an emergency

    condition with high blood glucose levels, a lack of insulin and an accumulation of ketones (chemicals) in the blood and urine). This condition should be treated with insulin.

  • Diabetic precoma or coma.
  • During stress conditions such as severe infections,

    trauma or surgery.

  • In the presence of liver disease or frank jaundice; or

    kidney disease.

  • If you are being treated with bosentan.
  • If you are pregnant or breastfeeding.

What the medicinal ingredient is:

The medicinal ingredient for GLYBURIDE is glyburide.

What the important nonmedicinal ingredients are: GLYBURIDE tablets contain the following non-medicinal ingredients: colloidal silicon dioxide, magnesium stearate, sodium starch glycolate, pregelatinized starch and microcrystalline cellulose.

What dosage forms it comes in:

Tablets. Each tablet contains 2.5 mg or 5 mg glyburide.

WARNINGS AND PRECAUTIONS

Proper diet, exercise and weight reduction are important to help you control your diabetes.

Your blood glucose may change in some situations, for example if you are stressed or suffering from other illnesses (e.g. infections). At such times, your doctor may need to modify your dose.

GLYBURIDE may cause low blood sugar (hypoglycemia), especially if you miss a meal, exercise for a long time, drink alcohol or use another antidiabetic medication with GLYBURIDE.

Elderly patients may be more likely to experience low blood sugar with GLYBURIDE.

If your blood sugar gets too low, you may feel shaky, weak, drowsy, confused, or very hungry. You may sweat or have blurred vision, abnormal heartbeats, trouble concentrating, or a headache that doesn't go away. Signs of severe hypoglycemia can include disorientation, loss of consciousness, and seizures.

You should ask your doctor, pharmacist or diabetes educator about symptoms of low blood sugar and what to do if you experience these symptoms. Teach your friends, co-workers, or family members what they can do to help you if you have low blood sugar.

You should also test your blood sugar as instructed by your doctor.

Before you use GLYBURIDE talk to your doctor or pharmacist if:

  • You have or have had liver, kidney, or heart disease;
  • You are pregnant or planning to get pregnant;
  • You are breast-feeding.
  • You have a blood disease called G6PD-deficiency anemia
  • You have a heart disease.

GLYBURIDE is not recommended for use in children under 18 years of age.

Driving and Operating Machinery:

Alertness and reactions may be impaired due to low or high

blood sugar (hypo- or hyperglycemia), especially when

beginning or after changing treatment or when GLYBRUIDE is not taken regularly. This may affect your ability to drive or to operate machinery.

INTERACTIONS WITH THIS MEDICATION

Ask your doctor or pharmacist before taking any other medicine, including over-the-counter products.

Drugs that can interact with GLYBURIDE include: diuretics (water pills), corticosteroids (such as prednisone), ACE inhibitors (a drug used to treat high blood pressure (hypertension)), birth control pills, and some kinds of cold and allergy drugs.

Avoid drinking alcohol while you are taking GLYBURIDE.

PROPER USE OF THIS MEDICATION

Usual dose:

Take GLYBURIDE exactly as prescribed by your doctor.

The usual dose is 2.5 to 10 mg daily. Maximum daily dose is 20

mg.

A dose of more than 10 mg should be taken in two divided

doses.

Tablets should be taken during or immediately after meals.

Overdose:

Overdosage with this medication may result in hypoglycemia.

Missed Dose:

If you forget to take GLYBURIDE tablets, do not take a double dose to make up for forgotten individual doses.

Discuss with your healthcare for dealing with such mistakes (in

particular forgetting a dose or skipping a meal) or in the event a

dose cannot be taken at the prescribed time.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Side Effects:

As with any type of medication, GLYBURIDE is associated with some side effects.

The most common side effect of glyburide is low blood

sugar (hypoglycemia). Please see the WARNINGS and

PRECAUTIONS section above.

The following side effects have been observed with glyburide use: nausea, heartburn, feeling “full”, vomiting, diarrhea. abdominal pain and weight gain.

Allergic skin reactions (itchiness, rash, eruption) have been reported in a number of patients. An increased sensibility to light has been associated with the use of oral antidiabetic drugs.

Transient visual disturbances may occur at the beginning of the treatment due to variations in level of blood sugar.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking the drug and call your doctor or pharmacist
Only if severeIn all cases
Common

Low blood

sugar

(hypoglycemia)

✓
Uncommon

Skin reactions

(itchiness, rash,

eruption)

✓
Rare

Blood

disorders

(unusual

bruising or

bleeding)

✓
Very Rare

Liver problem

(yellowing of

the eyes or

skin)

✓

Allergic

reaction

(difficult

breathing,

hives, decreased blood pressure)

✓

Allergic

inflammation of blood vessels (vasculitis)

✓

In case of drug overdose, contact a health professional,

hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking the drug and call your doctor or pharmacist

Serious Skin

Reactions [bullous reactions

(Stevens-Johnson

Syndrome and Toxic Epidermal Necrolysis), drug rash with eosinophilia and systemic symptoms (DRESS),

exfoliative dermatitis and erythema multiforme]: any combination of red itchy rash with blisters and peeling of the skin and/or of the lips, eyes, mouth, nasal passages or genitals. It often goes with fever, chills, headache, cough, body aches or joint pain. You may have less or dark urine, yellow skin or eyes

✓

This list is not a complete list of side effects. If you have any

unexpected effects while taking this GLYBURIDE, contact your doctor or pharmacist.

HOW TO STORE IT

GLYBURIDE bottles should be stored between

15ºC -30ºC and protected from high humidity. Unit dose strips should be stored between 15 ºC -25°C and protected from high humidity.

REPORTING SIDE EFFECTS

You can help improve the safe use of health products for Canadians by reporting serious and unexpected side effects to Health Canada. Your report may help to identify new side effects and change the product safety information.

3 ways to report:

  • Online at MedEffect (http://hc-sc.gc.ca/dhp-mps/medeff/index-eng.php);
  • By calling 1-866-234-2345 (toll-free);
  • By completing a Consumer Side Effect Reporting Form and sending it by:

    • Fax to 1-866-678-6789 (toll-free), or
    • Mail to: Canada Vigilance Program

      Health Canada, Postal Locator 1908C

      Ottawa, ON

      K1A 0K9

Postage paid labels and the Consumer Side Effect Reporting Form are available at MedEffect (http://hc-sc.gc.ca/dhp-mps/medeff/index-eng.php).

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full Product Monograph, prepared for health professionals can be found by contacting Pro Doc Ltée at 1-800-361-8559, www.prodoc.qc.ca or info@prodoc.qc.ca

Pro Doc Ltée Laval, Québec H7L 3W9

Last revised: February 11, 2019

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 01959352

Revision date stated in the text: February 11, 2019

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Glyburide (Pro Doc)

Rx or OTC
Prescription (Rx)?
DIN 01959352, 02485664
Schedule(s) PRESCRIPTION
Active ingredient(s) Glyburide
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. A Alimentary tract and metabolism drugs
    1. A10 Drugs used in diabetes
      1. A10B Blood glucose lowering drugs, excl. insulins
        1. A10BB Sulfonylureas for blood glucose lowering
          1. A10BB01 Glibenclamide
Company PRO DOC LIMITEE
Current status Cancelled Post Market
Current status date June 17, 2024
Strengths and forms
DIN Strength Dosage form(s) Current status
01959352 2.5 MG Tablet Cancelled Post Market June 17, 2024
02485664 5 MG Tablet Cancelled Post Market June 17, 2024

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.